Fungal diseases are currently a serious public health problem, due to the limited number of fact-based effective principles, and the emergence of resistant strains to the polyenic antifungals. The aim of this study was to screen, for non-polyenic antifungals production by Actinobacteria, and to validate the screening program by characterizingthe produced compounds.Actinobacteria isolates were tested against four clinic human-pathogenic fungi isolated from Hospital Mohammed V Rabat, Morocco. The production of non-polyenic antifungal metabolites by active isolates was investigated based on the yeast cell specificity as challenging targets, antibacterial activity, activity against resistant Candida tropicalis R2 and Pythium irregular (resistant to polyenes), inhibition of antifungal activity by the addition of exogenous ergosterol, and the UV-visible light spectrophotometric analysis of the active crude extracts.The antifungal compound produced was purified using various chromatographic techniques and the selected producing strain was identified using the polyphasic approach.Among 480 Actinobacteria isolates, 55 showed antifungal activity against all tested clinically derived fungi. After performing the screening program, 4
The search for a new, safer, broad -spectrum antifungal antibiotic with greater potency has been progressing slowly (9) . The development of new antifungal agents, preferably naturally occurring with novel mechanisms of action, is an urgent medical need and the fungal cell is a promising drug target for antifungal therapy.
Microbial natural products have been one of the major sources to discover novel antifungals, and the chance of isolating new metabolites are low unless adequate isolation strategies are adopted.
Among the microorganisms, Actinobacteria are the most economically and biotechnologically useful prokaryotes (10) . They produce antibiotics and other industrially important secondary metabolites (11, 12) . Approximately 70% of all known antibiotics were isolated from actinomycetes, amongwhich 75% were employed in medicine and 60% in agriculture (13) .
The aim of the presentstudy wasto screen the non-polyenic antifungal compounds produced by Actinobacteria isolated from different Moroccan habitats, and to validate non-polyenic screening criteria by the identification of the producing strain and elucidation of the structure of elaboratedcompounds.
Materials and methods

Screening of actinomycetes for antifungal and antibacterial activity
The antifungal activity was tested by agar diffusion assay using 480 actinomycete isolates originating from various Moroccan ecosystems, such as rhizospherical soil, endophytic plants, Atlas
Mountain soil, and Sahara sand.
The isolated strains were spread over the entire surface of Bennett medium Petri dishes (14) .
As soon as the microorganism developed, agar discs were cut out using a cork borer (6 mm diameter), and were transferred to the surface of I 
Screening for antifungal non-polyenic metabolites
The selection of isolates producing only nonpolyenic antifungal metabolites was carried out using four-test-criteria: • The study of activity against Candida tropicalis R2 DSM11953 and Pythium irregular (CIP18) (resistant against polyenes such as amphotericin B and nystatin). 
Characterization of selected isolates
Culture, morphological and physiological cha- The physicochemical properties of the compound were determined using high resolution mass spectrometry(HRMS) and liquid chromatographymass spectrometry (LC-MS) analysis.
Results
Screening for non-polyenic antifungal substances
In this study, the total number of 480 actinomycete isolates was screened on Sabouraud agar medium, and a broad-spectrum of antibacterial and antifungal activities were observed. We found than Gram-negative bacteria. Also, they exhibited a high activity against Candida tropicalis R2 and
Pythium irregular (figure2).
Ergosterol present in fungal cell membrane has a very high affinity towards polyene antibiotics.
Polyene drugs form complexes with ergosterol, forming channels in the fungal membrane that cause leakage of critical intracellular constituents and subsequent cell death. This behavior is exploited in a detection method developed to identify the presence of polyene class antifungals.
Hence, variations in the inhibition diameters in the presence and absence of exogenous ergosterol in the culture medium indicates the implication of sterols as target of these active substances. Table 3 shows that the isolates 1 (AS25) and 2
do not show any differences in the inhibition zones with and without ergosterol in the medium. microorganisms. Therefore, we decided to identify it using the morphological, physiological and molecular characterization methods, and to purify the active substances produced to determine its chemical structure.
Taxonomic identification of AS25 isolate
The AS25 strain showed a good growth and abundant mycelia on all media used after 14 days of incubation at 30°C. The aerial mycelium was grayish white on Bennett and white on ISP1, ISP2, ISP3, ISP4, and ISP5. The substrate mycelium was yellowish white on ISP1 and Bennett, Brown on ISP2 and ISP5, but Grey on ISP3 and ISP4.
Diffusible and melanoid pigments were not produced on ISP7 and ISP6 (Table 4) . leucine and arginine, but not rhamnose and lactose. All data obtained with regard to the physiological and biochemical properties of the isolate, therefore, strongly confirmed that the strain belonged to the genus Streptomyces (Table 5 ).
In order to further support the findings related to the identification of AS25isolate, the 16S rRNA 
